Adams Hopeful For Mucinex Patent Despite Initial USPTO Decision

Adams Respiratory Therapeutics expects its most recent patent on Mucinex brand OTC cough/cold remedies to protect the product line's market exclusivity until 2020, despite a challenge to an earlier patent on the products